A Multiple Ascending Dose Study of LW402 in Healthy Volunteers

Clinical trial NCT07546149 · COMPLETED

Trial details

NCT number: NCT07546149
Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Evaluation of Escalating Doses

Start date: 2025-10-15
Primary completion: 2025-12-09
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.